Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study)

L. Molinos, A. Torres, J. Zalacain, R. Menendez, L. Borderias, J. Ruiz, M. Garcia (Oviedo, Barcelona, Baracaldo, Valencia, Huesca, Badalona, Mieres, Spain)

Source: Annual Congress 2005 - Treatment of respiratory infections
Session: Treatment of respiratory infections
Session type: Thematic Poster Session
Number: 4042
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Molinos, A. Torres, J. Zalacain, R. Menendez, L. Borderias, J. Ruiz, M. Garcia (Oviedo, Barcelona, Baracaldo, Valencia, Huesca, Badalona, Mieres, Spain). Use of pneumonia severity index in Spain to decide hospitalization among patients with community-acquired pneumonia (CAP). (Nacar Study). Eur Respir J 2005; 26: Suppl. 49, 4042

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is severity index enough to assess hospital admission of community-acquired pneumonia (CAP) patients?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


Physicians should not use the pneumonia severity index (PSI) or CRB-65 in deciding the need for hospitalization in cancer patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 41s
Year: 2007

Definition of severity and the reasons for hospitalization (RH) in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 641s
Year: 2005

The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study
Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia
Year: 2008


Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012

Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Use of ceftriaxone/sulbactame for treatment of mild-to-severe community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Treatment of airways disease
Year: 2009

Etiology of community-acquired pneumonia (CAP) in young hospital patients
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012


Clinical cure rates and infection types in the MOxifloxacin Treatment IV (MOTIV) study in hospitalized patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Clinical factors associated with delayed diagnosis in hospitalized community-acquired pneumonia (CAP). Impact on the outcome
Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia
Year: 2010



One year analysis of hospital-treated, community-acquired pneumonia (CAP)
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Optimizing treatment for community-acquired pneumonia in Denmark (The optiCAP study)
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018


Reasons that justify hospitalization for community-acquired pneumonia (CAP) patients with CURB-65 score 0-1
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008


Applicability of Fine criteria in patients hospitalized for community-acquired pneumonia (CAP)
Source: Eur Respir J 2005; 26: Suppl. 49, 67s
Year: 2005

Differential characteristics in elderly patients with community-acquired pneumonia (CAP) who required admission to ICU
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Community-acquired pneumonia (CAP): evaluation of severity criteria for hospitalization
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003

Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP)
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009

Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients
Source: Annual Congress 2011 - COPD management
Year: 2011